Lv2
140 积分 2026-06-14 加入
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation
1个月前
已完结
Adding HBV RNA and HBcrAg to HBsAg Improves Prediction of HBsAg Seroclearance in NAs-Suppressed CHB Treated With Peg-IFN-α
1个月前
已完结
Adding HBV RNA and HBcrAg to HBsAg Improves Prediction of HBsAg Seroclearance in NAs-Suppressed CHB Treated With Peg-IFN-α
1个月前
已完结
A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening
2个月前
已完结
皖公网安备34019202002308
